00954.HK
Changmao Biochemical Engineering Company Limited
HKSE · Basic Materials · Chemicals · CN
HKD 0.23
+0.89%Year over year
Reported trailing growth
- Revenue
- -16.5%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +75.1%
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -8.6%
- EBITDA
- -51.8%
- EBIT
- +15.2%
- Net income
- +2.2%
- EPS
- +0.0%
- Free cash flow
- +110.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025